Showing 321 - 340 results of 824 for search '"interferon"', query time: 0.04s Refine Results
  1. 321

    Linfangioma circunscrito zosteriforme. Presentación de un caso by María Irene Guerrero, Carmen Graciela Santamaría Burgos, José Luis Ramírez Osorio, Giselle Fernández García

    Published 2013-04-01
    “…Como tratamiento se utilizó el interferón alfa y la cirugía en parte de las lesiones. …”
    Get full text
    Article
  2. 322

    The unexpected role of the STING protein in lipid metabolism by Vila, Isabelle K., Laguette, Nadine

    Published 2023-04-01
    “…In the past decade, the stimulator of interferon genes (STING) adaptor protein has emerged as a central platform enabling the activation of inflammatory responses in the presence of cytosolic DNAs. …”
    Get full text
    Article
  3. 323

    The Challenge of Recurrent Hepatitis C Virus in Liver Transplant Recipients by Paul J Marotta

    Published 2004-01-01
    “…Nevertheless, these agents have some efficacy, and pegylated interferons, which are now being used more frequently, achieve superior response rates. …”
    Get full text
    Article
  4. 324
  5. 325

    Cytokines and Angiogenesis in the Corpus Luteum by António M. Galvão, Graça Ferreira-Dias, Dariusz J. Skarzynski

    Published 2013-01-01
    “…Using the mare CL as a model, reports on locally produced cytokines, such as tumor necrosis factor α (TNF), interferon gamma (IFNG), or Fas ligand (FASL), pointed out their role on angiogenic activity modulation throughout the luteal phase. …”
    Get full text
    Article
  6. 326

    Targeting Toll-Like Receptors for Treatment of SLE by Christopher G. Horton, Zi-jian Pan, A. Darise Farris

    Published 2010-01-01
    “…Activation of these TLRs results in the production of inflammatory cytokines and type I interferon. Genome-wide association studies, single nucleotide polymorphism analyses as well as experimental mouse models have provided evidence of TLR signaling involvement in SLE and other autoimmune diseases. …”
    Get full text
    Article
  7. 327

    Genetic Associations in Acquired Immune-Mediated Bone Marrow Failure Syndromes: Insights in Aplastic Anemia and Chronic Idiopathic Neutropenia by Irene Mavroudi, Helen A. Papadaki

    Published 2012-01-01
    “…Various alleles and haplotypes of human leucocyte antigen (HLA) molecules have been implicated in the predisposition of developing the above diseases, as well as polymorphisms of inhibitory cytokines such as interferon-γ, tumor necrosis factor-α, and transforming growth factor-β1 along with polymorphisms on molecules of the immune system including the T-bet transcription factor and signal transducers and activators of transcription. …”
    Get full text
    Article
  8. 328

    Respuesta inmune en terneros experimentalmente infectados con diferentes dosis de Mycobacterium bovis by F.C. BLANCO, M.V. BIANCO, V. MEIKLE, S. GARBACCIO, L. VAGNONI, A. A. CATALDI, F. BIGI

    Published 2011-01-01
    “…Tambien se observo que el nivel de produccion de interferon gama (IFN-.) por celulas monociticas de sangre periferica no se asocia a la dosis de inoculo.…”
    Get full text
    Article
  9. 329

    Recent Advances in Antiviral Therapy for Chronic Hepatitis C by Akihiro Tamori, Masaru Enomoto, Norifumi Kawada

    Published 2016-01-01
    “…Due to their increased efficacy, safety, and tolerability, interferon-free oral therapies with DAAs have been approved for patients with HCV, including those with cirrhosis. …”
    Get full text
    Article
  10. 330

    Case report: Generalized granuloma annulare successfully treated with baricitinib in two cases by Marina Yunoki, Shumpei Kondo, Masaki Otsuka, Yoshiki Tokura, Yoshiki Tokura

    Published 2025-01-01
    “…Given increased JAK1 signaling, high interferon-α and -γ production and macrophage activation in granuloma annulare, JAK inhibitors are considered to be a reasonable choice for recalcitrant generalized granuloma annulare. …”
    Get full text
    Article
  11. 331

    Eales’ Disease: When the Rare Sounds Frequent by Beatriz Oliveira Lopes, Margarida Sena Brízido, Ana Isabel Reis, Margarida Maria Miranda, Susana Morais Pina

    Published 2021-01-01
    “…Tuberculin skin sensitive test (Mantoux screening test) and interferon-gamma release assay (IGRA) were positive in all patients. …”
    Get full text
    Article
  12. 332

    Natural Killer Cell and Large Granular Lymphocyte Deficiency in the Gut of Children with Inflammatory Bowel Disease by F Hadziselimovic, LR Emmons, U Schaub

    Published 1990-01-01
    “…The authors also present a new therapeutic strategy consisting of low dose interferon-alpha-2a that is efficacious in ameliorating ulcerative col iris and Crohn's disease and concomitantly increasing the number of natural killer cells and LGL in the gut.…”
    Get full text
    Article
  13. 333

    Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis by Kailei Guo, Xiaomin Zhang

    Published 2021-01-01
    “…This article briefly describes the structures, mechanisms, and targeted drugs of cytokines—including interleukin (IL)-6, transforming growth factor-β1 (TGF-β1), IL-1β, IL-23, IL-27, IL-35, IL-2, IL-4, IL-21, and interferon (IFN)-γ—which have an important influence on the differentiation of Th17 cells and discusses their potential as therapeutic targets for treating autoimmune uveitis.…”
    Get full text
    Article
  14. 334

    Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial by Graham McIlroy, Charlotte Gaskell, Aimee Jackson, Emily Yafai, Rachel Tasker, Catherine Thomas, Sonia Fox, Rebecca Boucher, Fitsum Ghebretinsea, Claire Harrison, Adam J. Mead, Mary Frances McMullin

    Published 2025-01-01
    “…Combining a JAK2 inhibitor with an interferon may be synergistic, as haematopoietic cells are activated from quiescence (a typical kinase resistance mechanism) rendering them more sensitive to inhibition. …”
    Get full text
    Article
  15. 335

    The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program by V. T. Ivashkin, M. V. Mayevskaya, D. T. Abdurakhmanov, I. G. Bakulin, N. I. Geyvandova, M. L. Zubkin, S. N. Kizhlo, A. V. Kuznetsova, I. B. Latysheva, N. A. Mamonova, V. G. Morozov, O. I. Sagalova, Ye. V. Esaulenko, Ye. O. Lyusina

    Published 2018-08-01
    “…Before official registration of interferon-free treatment modes in 2015 experience of the application was limited to clinical trials or treatment within early approach programs. …”
    Get full text
    Article
  16. 336

    Propofol Suppresses Proinflammatory Cytokine Production by Increasing ABCA1 Expression via Mediation by the Long Noncoding RNA LOC286367 by Xin Ma, Teng Wang, Zhen-Long Zhao, Yu Jiang, Shu Ye

    Published 2018-01-01
    “…Moreover, propofol treatment downregulated the production of the proinflammatory cytokines interleukin-6, tumor necrosis factor, and interferon gamma in lipopolysaccharide-stimulated macrophages by enhancing ABCA1 expression. …”
    Get full text
    Article
  17. 337

    mGBP2 engages Galectin-9 for immunity against Toxoplasma gondii. by Elisabeth Kravets, Gereon Poschmann, Sebastian Hänsch, Veronica Raba, Stefanie Weidtkamp-Peters, Daniel Degrandi, Kai Stühler, Klaus Pfeffer

    Published 2025-01-01
    “…Guanylate binding proteins (GBPs) are large interferon-inducible GTPases, executing essential host defense activities against Toxoplasma gondii, an invasive intracellular apicomplexan protozoan parasite of global importance. …”
    Get full text
    Article
  18. 338

    The Management of Chronic Viral Hepatitis: A Canadian Consensus Conference 2004 by Morris Sherman, Vincent Bain, Jean-Pierre Villeneuve, Robert P Myers, Curtis Cooper, Steven Martin, Catherine Lowe

    Published 2004-01-01
    “…The conference issued recommendations on the investigation and management of chronic hepatitis B, including the use of lamivudine, adefovir and interferon. The treatment of hepatitis B in several special situations was also discussed. …”
    Get full text
    Article
  19. 339

    Liver Transplantation and Hepatitis C by Nobuhisa Akamatsu, Yasuhiko Sugawara

    Published 2012-01-01
    “…Antiviral treatment with pegylated interferon and ribavirin is currently considered the most promising regimen with a sustained viral response rate of around 30% to 35%, although the survival benefit of this regimen remains to be investigated. …”
    Get full text
    Article
  20. 340

    Herpes Simplex Virus and Human Papillomavirus Coinfections in Hyperimmunoglobulin E Syndrome Presenting as a Conjunctival Mass Lesion by Mitra Akbari, Ramin Elmi

    Published 2017-01-01
    “…However, the mass lesion did not respond to anti-HPV therapy with topical interferon-α2b (IFN-α2b) and oral cimetidine but improved promptly after intravenous (IV) acyclovir, which is often administered for cutaneous herpetic lesions. …”
    Get full text
    Article